Jan 11, 2023 / 11:45PM GMT
Casey Rene Woodring - JPMorgan Chase & Co, Research Division - Research Analyst
Great. Thank you, everybody. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to introduce our next presenting company, Azenta Life Sciences.
Joined with me here on stage is CEO, Steve Schwartz. Azenta is going to give a presentation, followed by a Q&A session. But with that, I'll just give it to Steve.
Stephen S. Schwartz - Azenta, Inc. - CEO, President & Director
Great. Thanks, Casey, and good afternoon, everyone. I just want to start with -- I'm here for the distance. I hope my voice will come along with me, so I apologize. But it's good to see everyone and Casey, we're delighted to be here at the JPMorgan conference. So we really appreciate the invitation and the opportunity to present.
As Casey mentioned, I'm Steve Schwartz. I'm the CEO of Azenta Life Sciences. We've been -- Azenta now is a stand-alone life sciences company for a year. So we just passed our 1-year anniversary as a stand-alone
Azenta Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot